Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2009-02-28
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Sleep Restriction on Gastric Emptying, Appetite and Energy Intake
NCT05953285
Chronic Sleep Restriction
NCT01493661
Effects of Sleep Deprivation on Food Intake and Motor Activity in Man
NCT00986492
Overnight Weight Loss and Sleep Structure
NCT00915642
Metabolic Effects of Sleep Extension in People With Obesity
NCT03594994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators aim to recruit 20 young adults, 10 obese and 10 normal weight individuals. The study will be conducted as a randomized, crossover study with three conditions. Each participant will be subjected to reduction of the beginning of sleep (from 3-7h), reduction of the end of sleep (from 23-3h), and normal sleep (from 23-7h), in random order, for three consecutive nights.
In each condition, subjects will stay for 4 days in the laboratory. Three control meals will be offered. Visual analogue scales will be applied before and after each meal to assess hunger and appetite for different food categories. Blood samples will be collected hourly during 24 hours.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obesity
BMI \> 30kg/m2
No interventions assigned to this group
Normal weight
BMI between 19 and 24,9kg/m2
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular time of sleep between 6.5 and 8 hours
Exclusion Criteria
* Obstructive sleep apnea (AHI \> 5 in polysomnography)
* night work;
* variable sleep habits or habitual daytime naps;
* regular physical exercise (\>3 hours/week);
* excessive intake of alcohol (\>7 drinks/week);
* excessive intake of caffeine (\>300 mg/day);
* smoking;
* substance abuse;
* use of prescription medications or over-the-counter drugs affecting sleep or metabolism;
* chronic diseases (e.g. cancer, asthma, back pain, thyroid disease, heart disease, diabetes, etc.)
* history of neurological, medical or sleep disorders;
* trans-meridian travelling the last month;
* chronotype: extreme morning or extreme evening
* unable to comply with the protocol.
20 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Associacao Fundo de Incentivo a Psicofarmcologia
OTHER
Centro de Estudos em Sonolência e Acidentes
OTHER
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iona Zalcman Zimberg
PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Tulio de Mello, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Estudos em Psicobiologia e Exercicio (CEPE)
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAPESP2008/09565-2
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CEPE18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.